Phosphoinositide 3-kinase gamma–Protein kinase A protein–protein interface (PI3Kγ–PKA PPI)

The Phosphoinositide 3-kinase gamma–Protein kinase A (PI3Kγ–PKA) protein–protein interface is a specialized regulatory site in cardiomyocytes where PI3Kγ functions as a non-catalytic scaffold. In this role, PI3Kγ acts as an A-kinase anchoring protein (AKAP) that binds to the regulatory subunits of PKA (specifically PKA-RIα), facilitating the recruitment of phosphodiesterases (PDEs) like PDE3 and PDE4 to degrade local cyclic AMP (cAMP) [1][4]. This scaffolding function is a critical determinant of cardiac contractility and calcium handling, independent of PI3Kγ's enzymatic kinase activity [2]. In pathological states such as chronic heart failure, the PI3Kγ–PKA interaction is often upregulated or dysregulated, leading to abnormally low cAMP levels and impaired myocardial performance [2][3]. Therapeutic strategies targeting this interface utilize small molecules or peptidomimetics to disrupt the PPI, which restores local cAMP signaling and enhances the phosphorylation of key proteins like phospholamban to improve heart function [1]. This approach offers a novel mechanism for treating cardiovascular disease by modulating protein localization rather than inhibiting enzymatic activity, potentially reducing the side effects associated with systemic kinase inhibition.

Other names

PI3Kgamma-PKA interactionPI3Kgamma-PKA complexPI3Kgamma-AKAP complexPI3Kgamma scaffolding interface

Disruption of the physical interaction between the PI3Kγ scaffold and the PKA regulatory subunit to prevent the recruitment of phosphodiesterases (PDEs), thereby increasing local cAMP concentrations and enhancing the phosphorylation of calcium-handling proteins.